نتایج جستجو برای: phenylketonurias

تعداد نتایج: 791  

Journal: :Molecular genetics and metabolism 2005
Nilo Lambruschini Belén Pérez-Dueñas Maria Antonia Vilaseca Anna Mas Rafael Artuch Rosa Gassió Lilian Gómez Alejandra Gutiérrez Jaume Campistol

The clinical, nutritional, and neuropsychological data of 11 mild/moderate PKU patients after one year of treatment with BH4 are evaluated. BH4 monotherapy was introduced at 5 mg/kg/day in 14 PKU patients. In 11/14 patients, Phe tolerance increased significantly from 356+/-172 to 1546+/-192 mg/day (p=0.004), and special PKU formula was gradually reduced until complete removal. In them, mean pla...

Journal: :Molecular genetics and metabolism 2005
Richard Koch Kathryn Moseley Flemming Guttler

A 29-year-old woman with PKU is presented, who was successfully treated with phenylalanine restriction as well as oral BH4 during this pregnancy, with a normal outcome. Her PAH mutation was R408W/F39L. Remarkably, the blood phenylalanine control was easily accomplished during this pregnancy. The lack of nausea and vomiting during the first trimester suggests that the occurrence of CHD in babies...

Journal: :Acta paediatrica 2000
R M Henderson D L McCulloch A M Herbert P H Robinson M J Taylor

Visual event-related potentials (ERPs) were examined in 16 children (aged 5-14 y) with phenylketonuria (PKU) and 16 age- and sex-matched controls. Lifetime median measures of phenylalanine (Phe) were 230-460 micromol/l. The most recent Phe levels were 56-624 micromol/l. ERPs were recorded whilst the children performed a discrimination task. All stimuli were square wave gratings degree, which ap...

2017
Ewa Witalis Bozena Mikoluc Radoslaw Motkowski Jolanta Sawicka-Powierza Agnieszka Chrobot Bozena Didycz Agata Lange Renata Mozrzymas Andrzej Milanowski Maria Nowacka Mariola Piotrowska-Depta Hanna Romanowska Ewa Starostecka Jolanta Wierzba Magdalena Skorniewska Barbara Iwona Wojcicka-Bartlomiejczyk Maria Gizewska Halina Car

BACKGROUND The aim of the study was to assess both patients' and their parents' knowledge of phenylketonuria (PKU) treatment and compliance with PKU diet. METHODS The study included 173 PKU patients aged 10-19 and 110 parents of PKU children who were enrolled in the study on the basis of questionnaire data. The study also included 45 patients aged ≥20. RESULTS Our study demonstrated that on...

Journal: :Journal of medical genetics 1988
J F Brookfield R J Pollitt I D Young

Limitation of family size after the birth of a child with a serious disorder poses a problem in demonstrating autosomal recessive inheritance. In this paper methods are presented for distinguishing autosomal recessive inheritance given a 100% deterrent effect, and revealing a partial deterrent effect by analysis of sibship size and comparison with general population data. These methods are illu...

Journal: :The Proceedings of the Nutrition Society 1968
L I Woolf

Galactosaemia, phenylketonuria and homocystinuria are inborn errors of metabolism as the term was defined by Garrod (1908). I n all three lack of an enzyme causes a metabolic block and accumulation of the substrate of the missing enzyme, and all three are inherited as Mendelian recessive characters. Unlike Garrod's original examples, galactosaemia, phenylketonuria and homocystinuria are often a...

Journal: :Pediatrics 2014
Coleen A Boyle Joseph A Bocchini James Kelly

Newborn screening (NBS) began 50 years ago with the ability to screen for phenylketonuria from dried-blood spots and prevent long-term disability through dietary intervention. Now nearly all of the 4 million infants born in the United States are screened for a wide array of significant medical conditions by using dried-blood spots and pointof-care tests, leading to early diagnosis and treatment...

Journal: :Genetics 1963
J H SANG B BURNET

N his studies of the eyeless mutation of Drosophila melanogaster, MORGAN I(1929) showed that penetrance and expressivity of this gene was dependent upon the environment, since the frequency and extent of the defect was different for flies hatching early or late during the life of a culture. He also demonstrated that both aspects of gene manifestation could be altered by selection. These consequ...

Journal: :Proceedings of the National Academy of Sciences of the United States of America 2004
Heidi Erlandsen Angel L Pey Alejandra Gámez Belén Pérez Lourdes R Desviat Cristina Aguado Richard Koch Sankar Surendran Stephen Tyring Reuben Matalon Charles R Scriver Magdalena Ugarte Aurora Martínez Raymond C Stevens

Phenylketonuria patients harboring a subset of phenylalanine hydroxylase (PAH) mutations have recently shown normalization of blood phenylalanine levels upon oral administration of the PAH cofactor tetrahydrobiopterin [(6R)-L-erythro-5,6,7,8-tetrahydrobiopterin (BH4)]. Several hypotheses have been put forward to explain BH4 responsiveness, but the molecular basis for the corrective effect(s) of...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید